539 results on '"Vallera, Daniel A."'
Search Results
2. Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation
3. Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML
4. General Strategies in In Vivo Animal Modeling
5. Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy
6. Data from Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings
7. Supplementary Data from Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings
8. Supplementary Materials from Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
9. Data from Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
10. Methods and figures from ImmunoPET, [64Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model
11. Data from ImmunoPET, [64Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model
12. Supplemental Table 2 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
13. Supplemental Figure Legends from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
14. Supplementary Figure 2 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
15. Supplementary Figure 1 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
16. Supplemental Table 1 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
17. A tri-specific killer engager against mesothelin targets NK cells towards lung cancer
18. Eradication of Heterogeneous Tumors by T-Cells Targeted with Combination Bispecific Chemically Self-Assembled Nanorings (CSANs)
19. 1202 Tri-specific killer engagers target natural killer cells towards mesothelioma
20. CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
21. Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA.
22. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
23. Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinoma
24. Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells
25. Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia
26. A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma
27. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia
28. 444 GTB-3550 tri-specific killer engager TriKE™ drives NK cells expansion and cytotoxicity in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) patients
29. Susceptibility to Immune Elimination of Epithelial and Quasi-mesenchymal Pancreatic Ductal Adenocarcinoma Cells under Basal Conditions and Following Treatment with FOLFIRINOX
30. Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
31. Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy
32. Anti-T-Cell Reagents for Human Bone Marrow Transplantation: Ricin Linked to Three Monoclonal Antibodies
33. Diphtheria toxin-based targeted toxin therapy for brain tumors
34. Immunotoxin targeting CD133+ breast carcinoma cells
35. Identification and characterization of a novel scFv recognizing human and mouse CD133
36. Bispecific Targeted Toxin DTATEGF Against Metastatic NSCLC Brain Tumors
37. Contributors
38. A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer
39. Intracerebral infusion of the bispecific targeted toxin DTATEGF in a mouse xenograft model of a human metastatic non-small cell lung cancer
40. A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature
41. Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery
42. Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model
43. Potent Cytolytic Activity and Specific IL15 Delivery in a 2(nd) Generation Trispecific Killer Engager
44. Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13
45. Targeting the Over-Expressed Urokinase-Type Plasminogen Activator Receptor on Glioblastoma Multiforme
46. Immunotoxin therapy for CNS tumor
47. Hemangiosarcoma and its cancer stem cell subpopulation are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors
48. GTB-3550 TriKE™ for the Treatment of High-Risk Myelodysplastic Syndromes (MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML) Safely Drives Natural Killer (NK) Cell Proliferation At Initial Dose Cohorts
49. 470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors
50. A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.